Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2008
03/13/2008CA2662112A1 Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators
03/13/2008CA2661315A1 Pyridin-3-yl derivatives as immunomodulating agents
03/13/2008CA2661105A1 Pyridin-4-yl derivatives as immunomodulating agents
03/13/2008CA2661102A1 Thiophene derivatives as s1p1/edg1 receptor agonists
03/12/2008EP1897879A2 2,4,5 substituted piperidines as renin inhibitors
03/12/2008EP1896465A1 Heterocyclic non-peptide gnrh antagonists
03/12/2008EP1896464A1 Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors
03/12/2008EP1896463A2 Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
03/12/2008EP1896462A2 Substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
03/12/2008EP1896456A2 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
03/12/2008EP1896453A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
03/12/2008EP1896428A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders
03/12/2008EP1896421A2 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
03/12/2008EP1896023A2 Chemokine receptor binding compounds
03/12/2008EP1896014A2 Chemical compounds
03/12/2008EP1708713B1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d)(1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system
03/12/2008EP1697345B1 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
03/12/2008EP1656355B1 Piperazine derivatives and methods of use
03/12/2008EP1587799B1 Benzoxazole derivatives and their use as adenosine receptor ligands
03/12/2008EP1581229B1 Phthalazine derivatives as phosphodiesterase 4 inhibitors
03/12/2008EP1560815B1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
03/12/2008EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
03/12/2008EP1414809B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
03/12/2008CN101142212A 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
03/12/2008CN101142209A Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
03/12/2008CN101142198A Isoxazole combretastatin derivatives for the treatment of proliferative disorders
03/12/2008CN101142192A 1,2-diphenyl-imidazole derivatives and their use as CB1 receptor ligands
03/12/2008CN101142189A 2-pyridine derivatives as inhibitors of neutrophile elastase
03/12/2008CN101142184A Sulfonamide peri-substituted bicyclics for occlusive artery disease
03/12/2008CN101139346A Benzimidazole-derivatives as factor Xa inhibitors
03/12/2008CN101139340A N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
03/12/2008CN101139317A Organic semiconductor material containing carbazole unit and synthesis
03/12/2008CN100374434C Microbiocidal N-Phenyl-N-[4-pyridyl-pyrimidin-2-yl]-amine derivatives
03/12/2008CN100374428C Intermediary compounds for the hemisynthesis of taxanes and prepn. processes therefore
03/12/2008CN100374427C Cyclic compound, process for producing the same, and pest control agent
03/12/2008CN100374420C Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
03/11/2008US7342115 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology
03/11/2008US7342113 Colorant compositions
03/11/2008US7342037 Anti-inflammatory medicaments
03/11/2008US7342035 Process for preparing zolmitriptan compounds
03/11/2008US7342027 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
03/11/2008US7342022 Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3
03/11/2008US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching
03/11/2008CA2485298C Substituted pyrazolyl compounds for the treatment of inflammation
03/11/2008CA2421880C Resorcinol derivatives
03/11/2008CA2404464C Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders
03/11/2008CA2293382C Piperazine derivatives and their use as anti-inflammatory agents
03/11/2008CA2223535C 2,4-pentadienoic acid derivatives having retinoid-like biological activity
03/11/2008CA2192764C Integrin receptor antagonists
03/06/2008WO2008027542A2 5-substituted isoindoline compounds
03/06/2008WO2008026564A1 Urea derivative
03/06/2008WO2008026216A2 Process for purification of aprepitant
03/06/2008WO2008026046A1 Morpholine d3 dopamine antagonists
03/06/2008WO2008025798A1 Pyridine compounds for treating gpr119 related disorders
03/06/2008WO2008025540A1 Heterocyclic fxr binding compounds
03/06/2008WO2008025539A1 Heterocyclic fxr binding compounds
03/06/2008WO2008011110A3 Di-amino-substituted heterocyclic compounds and methods of use
03/06/2008WO2008008327A3 Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound
03/06/2008WO2008007390A3 An improved process for purification of zolmitriptan
03/06/2008WO2008006795A3 Indole compounds
03/06/2008WO2007131201A3 Compounds and compositions as hedgehog pathway modulators
03/06/2008WO2007125398A3 : sulfonamide compounds as antagonists of the n-type calcium channel
03/06/2008WO2007117607A9 Quinazolines for pdk1 inhibition
03/06/2008WO2007103252A3 Novel crystalline forms of antidiabetic compounds
03/06/2008US20080058515 indazolylacrylamide derivatives are useful in the treatment of diseases associated with inappropriate SGK-1 activity
03/06/2008US20080058398 1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane tartrate; antipsychotic agents; nuclear magnetic resonance
03/06/2008US20080058387 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
03/06/2008US20080058376 Useful in treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels; treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels; neuropathic pain
03/06/2008US20080058347 Novel aminopyridine derivatives having aurora a selective inhibitory action
03/06/2008US20080058334 Dermatological or oncological disorders; N-(4-fluorophenyl)-N'-[4-[1-(1H-imidazol-1-yl)-2-methylpropyl]phenyl]urea for example
03/06/2008US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis
03/06/2008US20080058332 Antiproliferative, antitumor agents; 4-(3-hydroxyphenyl)-6-morpholino-2-(3-piperidin-4-ylcarbonylaminophenyl)pyrimidine for example
03/06/2008US20080058328 Substituted 4-phenyltetrahydroisoquinolines, pharmaceuitcal compositions comprising them and therapeutic methods for their use
03/06/2008US20080058326 Interfere with Tie2 signalling; Tie (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain) receptor tyrosine kinase; antitumor, antimetastasis agents; for example, 1-[4-(6-tert-Butyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-phenyl]-3-(3-ethyl-phenyl)-urea
03/06/2008US20080058325 Compounds, methods and pharmaceutical compositions for inhibiting parp
03/06/2008US20080058324 Alpha-Keto Carbonyl Calpain Inhibitors
03/06/2008US20080058323 Therapy of vascular system diseases
03/06/2008US20080058320 Organic Compounds
03/06/2008US20080058319 Fused ring heterocycles as potassium channel modulators
03/06/2008US20080058315 Integrase inhibitors
03/06/2008US20080058297 Heterocyclic Compounds For Preventing And Treating Disorders Associated With Excessive Bone Loss
03/06/2008US20080057074 Nitrogenous Heterocylic Derivative and Medicine Containing the Same as an Active Ingredient
03/06/2008US20080056991 Histamine H3 receptor inhibitors; (4-Azepan-1-ylmethyl-phenyl)-(4-isopropyl-piperazin-1-yl)-methanone dihydrochloride for example; allergies, nasal congestion, eating disorders, sleep disorders, neurodegenerative disorders
03/06/2008DE102006039589A1 Aminoacyl-Prodrugs II Aminoacyl prodrugs II
03/06/2008CA2660806A1 5-substituted isoindoline compounds
03/06/2008CA2660699A1 Pyridine compounds for treating gpr119 related disorders
03/05/2008EP1894928A1 Heterocyclic fxr binding compounds
03/05/2008EP1894924A1 Heterocyclic FXR binding compounds
03/05/2008EP1893607A2 Inhibitors of checkpoint kinases
03/05/2008EP1893606A2 Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
03/05/2008EP1893603A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
03/05/2008EP1893600A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives
03/05/2008EP1893599A1 Compounds for the treatment of multi-drug resistant bacterial infections
03/05/2008EP1893598A1 Alkylquinoline and alkylquinazoline kinase modulators
03/05/2008EP1893592A1 Oxadiazole derivatives as dgat inhibitors
03/05/2008EP1893591A1 POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS
03/05/2008EP1893589A1 Substituted n-benzo [d] isoxazol-3-yl-amine derivatives as inhibitors of mglur5, serotonine (5-ht) and noradrenaline receptors, and the use thereof for producing medicaments
03/05/2008EP1893588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/05/2008EP1893581A1 Substituted arylpyrazoles for use against parasitites
03/05/2008EP1893573A1 Inhibitors of hcv replication
1 ... 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 ... 647